Marker Therapeutics Inc

NEW
FRA:GX1 (USA)  
€ 0.83 -0.080 (-8.74%) Aug 6
At Loss
P/B:
1.26
Market Cap:
€ 16.30M ($ 18.78M)
Enterprise V:
€ 3.40M ($ 3.91M)
Volume:
0
Avg Vol (2M):
0
Trade In:

Marker Therapeutics Inc (FRA:GX1) Dividend

Marker Therapeutics Inc (FRA:GX1) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -25.7%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:GX1 Dividend

Does Marker Therapeutics Inc (FRA:GX1) pay a dividend?

Marker Therapeutics Inc (FRA:GX1) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Marker Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Marker Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -25.7% over the past 3 years.

What are dividend-paying alternatives to Marker Therapeutics Inc?

For dividend-paying alternatives in Marker Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.